(Q40380967)

English

A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli

scientific article published on June 1, 1978

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli (English)

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Gram-negative bacteria

0 references

0 references

author name string

M. F. Parry

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A247895

29 January 2023

H. C. Neu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A247895

29 January 2023

language of work or name

0 references

publication date

1 June 1978

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0002934378904503?httpAccept=text/xml

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

https://api.elsevier.com/content/article/PII:0002934378904503?httpAccept=text/plain

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

961-966

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin

1

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Therapy of neutropenic rats infected with Pseudomonas aeruginosa

2

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats

3

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Recent Experience with Bacillemia Due to Gram-Negative Organisms

4

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Antibiotics and endotoxic shock

5

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections

6

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin

7

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

8

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Comparison of Amikacin and Tobramycin in the Treatment of Infection in Patients with Cancer

9

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Controlled Comparison of Amikacin and Gentamicin

10

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Tobramycin: an overview

12

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Comparative In Vitro Activity and Clinical Pharmacology of Ticarcillin and Carbenicillin

13

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Pharmacokinetics of Ticarcillin in Patients with Abnormal Renal Function

14

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration

15

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions

16

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic

18

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods

19

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

20

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis

21

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Gentamicin: toxicity in perspective

22

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

The hemostatic defect produced by carbenicillin

24

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Ticarcillin for treatment of serious infections with gram-negative bacteria.

25

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail

26

1 reference

10.1016/0002-9343(78)90450-3

https://api.crossref.org/works/10.1016/0002-9343(78)90450-3

29 January 2023

Identifiers

10.1016/0002-9343(78)90450-3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40380967&oldid=2148809545"